Aug 6, 2019 | News, Value Frameworks
In the debate over prescription drug prices, one group is being overlooked: people with rare diseases. The needs of these patients, who rely on specialty medications for their lives and livelihoods, must not be sacrificed in the quest to bring down drug costs. Yet...
Read more
Aug 6, 2019 | Federal Issues, Issues, Value Frameworks
WHAT IS ICER? An organization most patients never heard of is now hard at work determining whether recently approved drugs for serious and often life-threatening diseases should be covered by private health plans and made available to patients. Called the Institute...
Read more
